Cargando…

Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada

BACKGROUND & AIMS: HDV affects 4.5–13% of chronic hepatitis B (CHB) patients globally, yet the prevalence of HDV infection in Canada is unknown. To investigate the prevalence, genotype, demographics, and clinical characteristics of HDV in Canada, we conducted a retrospective analysis of (1) HDV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osiowy, Carla, Swidinsky, Ken, Haylock-Jacobs, Sarah, Sadler, Matthew D., Fung, Scott, Wong, David, Minuk, Gerald Y., Doucette, Karen E., Wong, Philip, Tam, Edward, Cooper, Curtis, Ramji, Alnoor, Ma, Mang, Nudo, Carmine, Tsoi, Keith, Coffin, Carla S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961228/ https://www.ncbi.nlm.nih.gov/pubmed/35360523 http://dx.doi.org/10.1016/j.jhepr.2022.100461

Ejemplares similares

Clinical Outcomes and Quantitative HBV Surface Antigen Levels in Diverse Chronic Hepatitis B Patients in Canada: A Retrospective Real-World Study of CHB in Canada (REVEAL-CANADA)
por: Coffin, Carla S., et al.
Publicado: (2022)

Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos(t)ide analogue
por: Ramji, Alnoor, et al.
Publicado: (2022)

Transmission of hepatitis D virus between spouses: A longitudinal study of the first reported Canadian case
por: Osiowy, Carla, et al.
Publicado: (2017)

Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD)
por: Joshi, Shivali S., et al.
Publicado: (2021)

Hepatitis B vaccination for Canadian children: time for an adult conversation
por: Coffin, Carla S., et al.
Publicado: (2021)

Systemic cytokine and viral antigen-specific responses in hepatitis D virus RNA positive versus HDV RNA negative patients
por: Joshi, Shivali S., et al.
Publicado: (2023)

Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog Therapy
por: Osiowy, Carla, et al.
Publicado: (2016)

A217 TREATMENT ADHERENCE OF CHRONIC HEPATITIS B PATIENTS WITH HEPATOCELLULAR CARCINOMA FROM THE CANHEPB NETWORK
por: Rahman, S H, et al.
Publicado: (2022)

Hepatitis B Virus Genotype Influence on Virological and Enzymatic Measures over Time—A Retrospective Longitudinal Cohort Study
por: Keeshan, Alexa, et al.
Publicado: (2023)

Characterization of Acute and Chronic Hepatitis B Virus Genotypes in Canada
por: Osiowy, Carla, et al.
Publicado: (2015)

Sa1389: LESSONS FROM HEPATITIS C TREATMENT DURING THE COVID-19 PANDEMIC: DECREASED RESOURCE UTILIZATION LEADS TO SIMILAR EFFICACY IN BRITISH COLUMBIA, CANADA
por: Jiang, Shirley X., et al.
Publicado: (2022)

Chronic hepatitis B carriers with acute on chronic liver failure show increased HBV surface gene mutations, including immune escape variants
por: Gao, Shan, et al.
Publicado: (2017)

The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)
por: Janjua, Naveed Z., et al.
Publicado: (2016)

Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants
por: Cooper, Curtis L., et al.
Publicado: (2020)

Differences in HBV Replication, APOBEC3 Family Expression, and Inflammatory Cytokine Levels Between Wild-Type HBV and Pre-core (G1896A) or Basal Core Promoter (A1762T/G1764A) Mutants
por: Lau, Keith C. K., et al.
Publicado: (2020)

Characterization of occult hepatitis B in high-risk populations in Kenya
por: Jepkemei, Kiptoon Beatrice, et al.
Publicado: (2020)

Hepatitis B virus serum RNA transcript isoform composition and proportion in chronic hepatitis B patients by nanopore long-read sequencing
por: Vachon, Alicia, et al.
Publicado: (2023)

From infancy and beyond… ensuring a lifetime of hepatitis B virus (HBV) vaccine-induced immunity
por: Osiowy, Carla
Publicado: (2018)

Hepatitis C treatment during the COVID-19 pandemic has similar efficacy with less resource utilization: analysis from the British Columbia HCV network
por: Jiang, Shirley, et al.
Publicado: (2022)

Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, Canada
por: Shaheen, Abdel Aziz, et al.
Publicado: (2022)

Editorial: Origin and Evolution of Hepatitis Viruses
por: Osiowy, Carla, et al.
Publicado: (2021)

Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management
por: Vachon, Alicia, et al.
Publicado: (2021)

Rat Hepatitis E Virus in Norway Rats, Ontario, Canada, 2018–2021
por: Robinson, Sarah J., et al.
Publicado: (2023)

Correction: Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients During Pregnancy and Post-Partum Follow-up
por: Virine, Boris, et al.
Publicado: (2015)

Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients during Pregnancy and Post-Partum Follow-Up
por: Virine, Boris, et al.
Publicado: (2015)

Increased hospital admissions for alcohol-associated hepatitis during the COVID-19 pandemic in Alberta, Canada: a retrospective cohort study
por: Frolkis, Alexandra, et al.
Publicado: (2022)

COVID‐19 and the Uncovering of Health Care Disparities in the United States, United Kingdom and Canada: Call to Action
por: Ala, Aftab, et al.
Publicado: (2021)

Hepatitis B Virus Genotype G: The Odd Cousin of the Family
por: Araujo, Natalia M., et al.
Publicado: (2022)

Identification and characterization of a G-quadruplex structure in the pre-core promoter region of hepatitis B virus covalently closed circular DNA
por: Meier-Stephenson, Vanessa, et al.
Publicado: (2021)

Public preferences for government spending in Canada
por: Ramji, Sabrina, et al.
Publicado: (2012)

Real-world Effectiveness of Sofosbuvir/Velpatasvir for Treatment of Chronic Hepatitis C in British Columbia, Canada: A Population-Based Cohort Study
por: Wilton, James, et al.
Publicado: (2020)

The Geographic Distribution of Liver Cancer in Canada Does Not Associate with Cyanobacterial Toxin Exposure
por: Labine, Meaghan A., et al.
Publicado: (2015)

The Health of Geriatrics in Canada —More Than Meets the Eye
por: Madden, Ken M., et al.
Publicado: (2013)

Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy
por: Janjua, Naveed Z., et al.
Publicado: (2019)

Chronic Hepatitis with Liver Granulomas in a Patient with Granuloma Annulare: A Case Report and Review of the Literature
por: Alsahafi, Majid, et al.
Publicado: (2017)

Delmarva (DMV/1639) Infectious Bronchitis Virus (IBV) Variants Isolated in Eastern Canada Show Evidence of Recombination
por: Hassan, Mohamed S. H., et al.
Publicado: (2019)

A Practical Guide for the Systemic Treatment of Biliary Tract Cancer in Canada
por: Ramjeesingh, Ravi, et al.
Publicado: (2023)

Estimating an individual-level deprivation index for HIV/HCV coinfected persons in Canada
por: Palayew, Adam, et al.
Publicado: (2021)

Tracing hepatitis B virus (HBV) genotype B5 (formerly B6) evolutionary history in the circumpolar Arctic through phylogeographic modelling
por: Bouckaert, Remco, et al.
Publicado: (2017)

Impact of Hepatitis B Virus Genetic Variation, Integration, and Lymphotropism in Antiviral Treatment and Oncogenesis
por: Lau, Keith C.K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u7f077773fm52o0qep912mno6v